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Abstract: In this study, we combined all-atom MD simulations, the ensemble-based mutational
scanning of protein stability and binding, and perturbation-based network profiling of allosteric
interactions in the SARS-CoV-2 spike complexes with a panel of cross-reactive and ultra-potent
single antibodies (B1-182.1 and A23-58.1) as well as antibody combinations (A19-61.1/B1-182.1 and
A19-46.1/B1-182.1). Using this approach, we quantify the local and global effects of mutations in the
complexes, identify protein stability centers, characterize binding energy hotspots, and predict the
allosteric control points of long-range interactions and communications. Conformational dynamics
and distance fluctuation analysis revealed the antibody-specific signatures of protein stability and
flexibility of the spike complexes that can affect the pattern of mutational escape. A network-based
perturbation approach for mutational profiling of allosteric residue potentials revealed how antibody
binding can modulate allosteric interactions and identified allosteric control points that can form
vulnerable sites for mutational escape. The results show that the protein stability and binding
energetics of the SARS-CoV-2 spike complexes with the panel of ultrapotent antibodies are tolerant to
the effect of Omicron mutations, which may be related to their neutralization efficiency. By employing
an integrated analysis of conformational dynamics, binding energetics, and allosteric interactions, we
found that the antibodies that neutralize the Omicron spike variant mediate the dominant binding
energy hotpots in the conserved stability centers and allosteric control points in which mutations may
be restricted by the requirements of the protein folding stability and binding to the host receptor. This
study suggested a mechanism in which the patterns of escape mutants for the ultrapotent antibodies
may not be solely determined by the binding interaction changes but are associated with the balance
and tradeoffs of multiple local and global factors, including protein stability, binding affinity, and
long-range interactions.
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1. Introduction
The rapidly growing body of structural, biochemical, and functional studies established that the mechanism of SARS-CoV-2 infection may involve conformational transitions
between distinct functional forms of the SARS-CoV-2 viral spike (S) glycoprotein [1–9].
The S protein consists of a conformationally adaptive amino (N)-terminal S1 subunit
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and structurally rigid carboxyl (C)-terminal S2 subunit, where S1 includes an N-terminal
domain (NTD), the receptor-binding domain (RBD), and two structurally conserved subdomains, SD1 and SD2, which coordinate the protein response to binding partners and
regulate the interactions with the host cell receptor ACE2. Conformational plasticity of the
SARS-CoV-2 S protein is exemplified by spontaneous transitions from the closed state to
the open state accompanied by large-scale movements of the RBDs that can spontaneously
fluctuate between the “RBD-down” and “RBD-up” positions, where binding to the host cell
receptor ACE2 preferentially stabilizes the receptor-accessible “up” conformation [1–12].
The cryo-EM experimental tools have been deployed at an unprecedented speed to characterize the dynamic structural changes in the SARS-CoV-2 S protein, revealing a spectrum
and atomic details of the prefusion S conformations that included various forms of the
closed “RBD-down” state, “partially open” trimers with only one or two RBDs in the “up”
conformation, and “open” trimers with all three RBDs in the “up” position [5–14]. The
cryo-EM and tomography tools examined conformational flexibility and distribution of the
S trimers in situ on the virion surface showing that the underlying physical mechanism of
spontaneous conformational changes between different functional open and closed S states
and the intrinsic properties of the conformational landscapes for SARS-CoV-2 S trimers are
preserved in different biological environments [15]. Single-molecule Fluorescence (Förster)
Resonance Energy Transfer (smFRET) studies have captured the intrinsically dynamic
nature of the SARS-CoV-2 S trimer, suggesting that conformational selection and receptorinduced structural adaptation of the S states can work synchronously, leading to diverse
mechanisms for antibody-induced neutralization [16]. Biophysical studies demonstrated
that conformational dynamics and allosteric regulation of the S protein are intrinsically
related, in which allosteric modulation of the RBD equilibrium can be a critical component
of the SARS-CoV-2 virus adaption strategies [17]. Allosteric modulation of the conformational dynamics and ligand-induced population shifts in the S protein was quantified using
an smFRET imaging assay showing that antibodies may allosterically promote a shift in
the RBD equilibrium toward the up conformation, enhancing ACE2 binding [18]. The
SARS-CoV-2 variants of concern (VOCs) are characterized by the enhanced transmissibility
and infectivity profiles, promoting immune evasion and partial vaccine escape [19–28]. The
Omicron variants (B.1.1.529, BA.1, BA.1.1, BA.2, BA.3, BA.4, and BA.5 lineages) [29–34] can
facilitate the evasion of immune responses induced by vaccination and confer resistance to
a wide spectrum of neutralizing antibodies that are one of the significant components for
adaptive immunity against viruses. Structural studies of the Omicron variant suggested
that evolutionary pressure invokes a complex interplay of thermodynamic factors between
mutations that increase affinity for the ACE2 with other RBD modifications that disfavor
ACE2 binding but facilitate immune escape [29,30]. These investigations suggested that
immune evasion may be a primary driver of Omicron evolution that sacrifices some ACE2
affinity enhancement substitutions to optimize immune-escaping mutations. Using surface
plasmon resonance (SPR) to measure binding of the RBD to human and mouse ACE2
receptors, it was demonstrated that the Omicron RBD has a 2.4-fold increased binding
affinity to human ACE2 [31]. A detailed thermodynamic and kinetics analysis of the
effect of five common S-RBD mutations (K417N, K417T, N501Y, E484K, and S477N) on
the binding affinity with ACE2 showed that the Omicron mutations N501Y and S477N
enhance transmission by enhancing binding, while K417N facilitates immune escape [32].
The antibody-escaping mutation profiles revealed that single Omicron mutations can impair neutralizing antibodies of different classes, particularly for antibodies targeting the
ACE2-binding epitopes that are escaped by the single mutations K417N, G446S, E484A, and
Q493R [33]. By evaluating monoclonal antibodies against all known epitope clusters on the
S protein, the activity of 17 out of the 19 currently authorized or approved antibodies were
impaired against the Omicron variant, revealing that mutations S371L, N440K, G446S, and
Q493R can confer greater antibody resistance [34]. The structure–function investigations of
the SARS-CoV-2 S Omicron variant in various functional states and complexes with antibodies reinforced and further detailed the diversity of neutralization escape mechanisms
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that can be determined by multiple fitness trade-offs balancing the tendency to evolve
mutations evading antibodies with mutational changes that preserve or enhance binding
affinity with ACE2 [35–40]. Structural analysis of the SARS-CoV-2 Omicron S protein
states showed that, unlike other VOCs implicated in the enhanced viral transmissibility
through mutation-induced stabilization of the open S states, the Omicron variant can lead
to the increased thermodynamic stabilization of the closed state and promote immune
evasion by occluding immunogenic sites [40]. These studies demonstrated that the intrinsic
conformational flexibility of the S protein, which is distinctly controlled by mutations, is an
important contributing factor of antibody escape induced by the Omicron variant.
Although the enhanced binding interactions of the S-RBD Omicron protein with ACE2
are often attributed to the greater infectivity of the Omicron variant, recent biophysical studies emphasized the role of mechanical stability as an additional mechanism for mediating
stronger virus–cell interactions and immune evasion [41–43]. Atomic force microscopy and
computer simulations examined the stability effects of several variants on the kinetic and
thermodynamic properties of the RBD–ACE2 complex formation, showing that the RBD
mutations in the different variants led in all cases to both the higher stability and affinity
of the RBD–ACE2 complex [41]. Single-molecule experiments that quantifies the molecular stiffness of the SARS-CoV-2 S proteins demonstrated that the S protein can exploit
mechanical force to enhance its recognition of ACE2 and subsequently accelerate S1/S2
detachment for effective invasion into host cells [42]. Another fascinating biophysical study
employed single-molecule force spectroscopy techniques to quantify the force stability of
the RBD–ACE2 interactions under physiological conditions, revealing the higher mechanical stability, greater binding free energy, and a lower dissociation rate for the SARS-CoV-2 S
protein as compared to SARS-CoV-1 [43]. These studies established a synergistic role of
mechanical forces, protein stability effects, and binding interaction factors in mediating the
spike association with the host receptor and antibodies that collectively control the virus
fitness advantage and immune escape mechanisms.
To understand the antigenic anatomy of the SARS-CoV-2 S protein, and the molecular
mechanisms of SARS-CoV-2 neutralization, several studies examined the diversity of the
binding epitopes in the structures of the antibody complexes and presented a detailed
classification of these antibodies into distinct categories [44–48]. Classes of neutralizing
antibodies that are characterized by direct ACE2 competition via binding RBD-up/down
conformations exhibit the highest potency but often suffer from the greatest sensitivity to
viral escape, whereas antibodies targeting cryptic epitopes that do not interfere with ACE2
binding are characterized by a reduced potency but displaying a greater breadth and tolerance to RBD mutations. Combinations and synergistic cocktails of different antibody classes
simultaneously targeting the conserved and more variable SARS-CoV-2 RBD epitopes can
provide more efficient cross-neutralization effects and yield resilience against mutational
escape [49,50]. Using an arsenal of biophysical tools, including antigen-based flow-sorting
and live virus neutralization assays, a recent study identified four antibodies (A19-46.1,
A19-61.1, A23-58.1, and B1-182.1) that target the RBD and neutralize the SARS-CoV-2 WA-1
original virus strain, while also maintaining potent neutralizing activity against 23 variants,
including B.1.1.7, B.1.351, P.1, B.1.429, B.1.526, B.1.529.1, B.1.617.1, and B.1.617.2 VOCs. [51].
The cryo-EM reconstructions for structures of the A23-58.1 and B1-182.1 bound to the
original Wuhan or WA1/2020 strain (S-WA1) revealed that the antibodies bind to the S
protein with all RBDs in the up position. An impressive structure–function tour-de-force
investigation of the impact of the SARS-CoV-2 S mutations on the binding and neutralization of monoclonal antibodies confirmed that many potent antibodies targeting the
spike RBD experienced a significant loss of binding for the B.1.1.529 variant [52]. Using
functional assays and cryo-EM structures of the S Omicron complexes with a large panel of
antibodies, this study identified that only A23-58.1, B1-182.1, COV2-2196, S2E12, A19-46.1,
S309, and LY-CoV1404 maintain substantial neutralization against the Omicron variant.
Class I B1-182.1 and class II A19-46.1 antibodies revealed potent neutralization of B.1.1.529,
while class III and IV antibodies that bind outside of the ACE2-binding surface (A19-61.1,
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COV2-2130, S309, and LY-CoV1404) can tolerate individual B.1.1.529 substitutions [52]. The
structure of the ternary complex of the Omicron complex with a combination of B1-182.1
and A19-46.1 antibodies targeting different binding epitopes and trapping three RBD-up S
conformations suggested a mechanism of the observed synergistic increase in neutralization
potency compared with that of the individual antibodies [52]. Analysis of the neutralization
profiles for a broad panel of antibodies against the Omicron sub-lineages showed that while
most antibodies lost neutralizing activity, some display a unique Omicron escape potential,
reflecting antigenic differences [53]. The effect of individual and combined mutations that
convergently appeared in different lineages was examined showing that the RBD sites
more dispensable for binding to ACE2 (particularly E484 and S494) can be hotspots for
immune evasion, and in combination with mutations that promote ACE2 binding, such as
N501Y, can increase escape neutralizing-antibody responses [54]. The recent investigation
identified two highly conserved cryptic regions on the S-RBD Omicron that are simultaneously and synergistically recognized by a bispecific single-domain antibody [55]. The
recent pioneering discoveries of broadly neutralizing antibodies that are effective against
multiple VOCs showed that they target highly conserved binding epitopes or conserved
cryptic regions, where the antibody-interacting RBD residues are rarely mutated in the
GISAID database [56]. Collectively, structural, functional, and biophysical studies revealed
the diversity of mechanistic scenarios underlying antibody binding and catalogued the
RBD escape mutations for a wide range of antibodies, revealing distinct signatures of
antibody-resistant mutational hotspots.
Computer simulations provided important atomistic and mechanistic insights into
understanding the dynamics and function of the SARS-CoV-2 glycoproteins. Molecular
dynamics (MD) simulations of the SARS-CoV-2 S proteins and mutants detailed conformational changes and diversity of ensembles, demonstrating enhanced functional and
structural plasticity of the S proteins [57–65]. All-atom MD simulations of the full-length
SARS-CoV-2 S glycoprotein embedded in the viral membrane, with a complete glycosylation profile, were performed by Amaro and coworkers, providing an unprecedented level
of detail about the conformational landscapes of the S proteins in the physiological environment [57]. Another landmark study from this laboratory reported 130 µs of weighted
ensemble simulations of the fully glycosylated S ectodomain and statistical characterization
of more than 300 kinetically unbiased RBD-opening pathways [58]. Together with the cryoelectron microscopy data and biolayer interferometry experiments, these integrative studies
revealed a gating role for the N-glycan at position N343 in facilitating RBD opening and
suggested that allosteric mechanisms are in play to control the balance between the closed
and open S conformations [58]. MD simulations of the S-protein in solution and targeted
simulations of conformational changes between the open and closed forms revealed the
key electrostatic interdomain interactions mediating the protein stability and kinetics of the
functional spike states [64]. MD simulations characterized the conformational landscapes
of the full-length S protein trimers detailing conformational transitions between functional
states and unveiling previously unknown cryptic pockets [65]. Our studies revealed that
the SARS-CoV-2 S protein can function as an allosteric regulatory machinery that can
exploit the intrinsic plasticity of functional regions controlled by stable allosteric hotspots
to modulate specific regulatory and binding functions [66–72]. A number of computational
studies employed atomistic simulations and binding energy analysis to examine the interactions between the S-RBD Omicron and the ACE2 receptor. Markov state modeling
of the conformational states and binding free energy calculations helped identified the
key mutational sites (S477N, G496S, Q498R, and N501Y) responsible for the enhanced
binding of ACE2 by the Omicron RBD [73]. The dynamics and energetics of the interactions
between the Omicron RBD and ACE2 was examined using MD simulations, confirming
the greater affinity of the Omicron variant as compared to the original S-WA1 strain [74].
Computational mutagenesis and binding free energy analysis showed that the RBD Omicron binds ACE2 approximately 2–3 times stronger than the original S-WA1 protein, where
the three mutational sites T478K, Q493K, and Q498R enhance the binding affinity through
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more favorable electrostatic interactions [75]. All-atom MD simulations of the S Omicron
trimer and the Omicron RBD–ACE2 complexes suggested that the Omicron mutations
may have evolved to inflict a greater infectivity using a combination of more efficient RBD
opening, the increased binding affinity with ACE2, and optimized capacity for antibody
escape [76]. The role of the electrostatic potentials in the RBD–ACE2 binding suggested
that the RBD mutations increasing the electropositive-charged residues may contribute to
the enhanced transmission by favoring binding with the electronegative-charged ACE2
receptors [77]. The effect of nonadditive, epistatic relationships among RBD mutations was
assessed using protein structure modeling by comparing the effects of all single mutants
at the RBD–ACE2 interfaces for the Omicron variants, showing that structural constraints
on the RBD can curtail the virus evolution for a more complete vaccine and antibody
escape [78]. By employing the conformational ensembles of the S-RBD Omicron variant
complexes with ACE2, we recently performed simulations and mutational scanning of the
interfacial RBD residues, showing that N501Y is the critical binding affinity hotspot in the
S Omicron RBD complex with ACE2, while hotspots Q493R, G496S, and Q498R anchor the
key interfacial clusters responsible for binding with ACE2 [79].
In the current study, we expanded on our previous investigations and employed a
battery of several computational approaches to examine the binding mechanisms of the
S-RBD Omicron protein with a set of ultra-potent antibodies that elicit significant neutralization of the Omicron variant and are resistant to or limit the antibody escape. We
combined all-atom MD simulations, mutational scanning of protein folding stability and
binding, and perturbation-based network profiling of allosteric interactions in the S-RBD
and S-RBD Omicron structures with a panel of cross-reactive single antibodies (B1-182.1
and A23-58.1) as well as combinations (A19-61.1/B1-182.1 and A19-46.1/B1-182.1). Using
these approaches, we quantify both the local and global effects of the RBD mutations,
identify protein stability centers, characterize binding energy hotspots, and predict the
allosteric control points of long-range interactions in the S-RBD Omicron complexes with
the antibodies. A network-based perturbation approach for mutational profiling of allosteric residues potentials is proposed that evaluates the effect of antibody binding on
modulation of allosteric interactions in the studied S-RBD complexes. Through analysis
of the conformational landscapes and systematic mutational profiling of binding, protein
stability, and allostery in the RBD–antibody complexes, this study quantifies the structural
and energetic factors of the binding mechanism that can contribute to the experimentally
observed pattern of limited antibody escape. Consistent with the experimental evidence,
mutational profiling reveals that local binding interactions and long-range allosteric communications in the complexes are generally tolerant to the Omicron mutations. The results
show that the dominant binding energy hotspots and allosteric centers of long-range interactions in the S-RBD Omicron complexes correspond to the same group of conserved
RBD residues—Y449, Y453, L455, F486, Y489, and F490—that are also vital for the RBD
stability and ACE2 binding. This study suggests that the antibody escape patterns may
not be solely determined by the binding interaction changes but are affected by both local
and global factors. The findings of this investigation suggest a plausible mechanism in
which binding of the antibodies to the conserved and “mutation-protected” RBD regions
may narrow the “ evolutionary path” for the virus, thereby allowing for the neutralization
efficiency against the Omicron variant. We suggest that the antibody escape mechanisms
are associated with the multiple fitness tradeoffs balancing the conformational plasticity
and local binding interactions, the RBD protein stability, and the functional control of global
structural changes mediated by allosteric hotspots.
2. Materials and Methods
2.1. Molecular Dynamics Simulations
All structures were obtained from the Protein Data Bank [80]. During structure preparation stage, protein residues in the crystal structures were inspected for missing residues
and protons. Hydrogen atoms and missing residues were initially added and assigned
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according to the WHATIF program web interface [81]. The missing loops in the studied
cryo-EM structures of the SARS-CoV-2 S protein were reconstructed and optimized using
the template-based loop prediction approaches ModLoop [82] and ArchPRED server [83].
The side chain rotamers were refined and optimized by SCWRL4 tool [84]. The protein
structures were then optimized using atomic-level energy minimization with composite
physics and knowledge-based force fields as implemented in the 3Drefine method [85].
The atomistic structures from the simulation trajectories were further elaborated by adding
N-acetyl glycosamine (NAG) glycan residues and were optimized. We performed 10 independent all-atom MD simulations (500 ns each simulation) for each of the following S-RBD
complexes: S-RBD with A23-58.1 (pdb id 7LRS), S-RBD with B1-182.1 (pd id 7MLZ), S-RBD
with A19-61.1/B1-182.1 (pdb id 7TBF), and S-RBD Omicron with A19-46.1/B1-182.1 (pdb id
7U0D) (Table 1), using the NAMD 2.13-multicore-CUDA package [86] with a CHARMM36
force field [87]. The all-atom additive CHARMM36 protein force field can be obtained from
http://mackerell.umaryland.edu/charmm_ff.shtml. (accessed on 17 March 2022). For each
system, multiple independent simulations were initiated from the same atomic coordinates
obtained from the experimental structures but with randomized initial velocities. The
equilibrium ensembles for the analysis were derived by aggregating the 10 independent
MD trajectories for every system.
Table 1. Structures of the SARS-CoV-2 S-RBD complexes examined in this study.
PDB

System

1 Simulation

# Simulations

7LRS

RBD/A23-58.1

500 ns

10

7MLZ

RBD/B1-182.1

500 ns

10

7TBF

RBD/A19-61.1/B1-182.1

500 ns

10

7U0D

RBD Omicron/A19-46.1/B1-182.1

500 ns

10

#: The Number of Simulations.

The structures of the SARS-CoV-2 S-RBD complexes were prepared in Visual Molecular Dynamics (VMD 1.9.3) [88] by placing them in a TIP3P water box with 20 Å thickness
from the protein. Assuming normal charge states of the ionizable groups, corresponding
to a pH = 7, sodium (Na+ ) and chloride (Cl− ) counter-ions were added to achieve charge
neutrality and a salt concentration of 0.15 M NaCl was maintained. All Na+ and Cl− ions
were placed at least 8 Å away from any protein atoms and from each other. The long-range
non-bonded van der Waals interactions were computed using an atom-based cutoff of 12 Å
with the switching function beginning at 10 Å and reaching zero at 14 Å. The SHAKE
method was used to constrain all bonds associated with hydrogen atoms. Simulations were
run using a leap-frog integrator with a 2-fs integration time step. The ShakeH algorithm of
NAMD was applied for water molecule constraints. The long-range electrostatic interactions were calculated using the particle mesh Ewald method [89] with a real space cut-off
of 1.0 nm and a fourth order (cubic) interpolation. Simulations were performed under
NPT ensemble with a Langevin thermostat and Nosé–Hoover Langevin piston at 310 K
and 1 atm. The damping coefficient (gamma) of the Langevin thermostat was 1/ps. The
Langevin piston Nosé–Hoover method in NAMD is a combination of the Nose–Hoover
constant pressure method [90] with piston fluctuation control implemented using Langevin
dynamics [91,92]. Energy minimization after addition of solvent and ions was conducted
using the steepest descent method for 100,000 steps. All atoms of the complex were first
restrained at their crystal structure positions with a force constant of 10 Kcal mol−1 Å−2 .
Equilibration was done in steps by gradually increasing the system temperature in steps of
20 K, starting from 10 K until 310 K, and at each step 1 ns equilibration was done keeping a
restraint of 10 Kcal mol−1 Å−2 on the protein Cα atoms. After the restrains on the protein
atoms were removed, the system was equilibrated for additional 10 ns. An NPT production
simulation was run on the equilibrated structures for 500 ns keeping the temperature at
310 K and at a constant pressure (1 atm).
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2.2. Distance Fluctuations Stability and Communication Analysis
We employed distance fluctuation analysis of the simulation trajectories to compute
the residue-based stability profiles. The fluctuations of the mean distance between each
pseudo-atom belonging to a given amino acid and the pseudo-atoms belonging to the
remaining protein residues were computed. The fluctuations in the mean distance between
a given residue and all other residues in the ensemble were converted into distance fluctuation stability indexes that measure the energy cost of the residue deformation during
simulations [93–96]. The distance fluctuation stability index for each residue is calculated
by averaging the distances between the residues over the simulation trajectory using the
following expression:
3k B T
ki =
(1)
h(di − hdi i)2 i
di = hdij i j∗

(2)

where dij is the instantaneous distance between residue i and residue j; k B is the Boltzmann
constant; T = 300 K; hi denotes an average taken over the MD simulation trajectory; and
di = hdij i j∗ is the average distance from residue i to all other atoms j in the protein (the sum
over j∗ implies the exclusion of the atoms that belong to the residue i). The interactions
between the Cα atom of residue i and the Cα atom of the neighboring residues i − 1 and
i + 1 are excluded in the calculation since the corresponding distances are constant. The
inverse of these fluctuations yields an effective force constant ki that describes the ease of
moving an atom with respect to the protein structure. The dynamically correlated residues
whose effective distances fluctuate with low or moderate intensity are expected to communicate over long distances with a higher efficiency than the residues that experience large
fluctuations. Our previous studies showed that residues with a high value of these indexes
often serve as protein stability centers and regulatory points of allosteric interactions and
communications, whereas small values of the distance fluctuation stability index are typically indicative of highly dynamic fluctuating sites [67–69]. The python scripts and tools
used for calculation of the distance fluctuations are reported in Supplementary Materials
Information and require the mdtraj, matplotlib, and cython modules.
2.3. Mutational Scanning and Sensitivity Analysis
Mutational sensitivity scanning of the SARS-CoV-2 S-RBD and S-RBD Omicron complexes with the studied antibodies were done using the BeAtMuSiC approach [97–99] and
the webserver at http://babylone.ulb.ac.be/beatmusic/index.php (accessed on 25 April
2022). The BeAtMuSiC server allows for a systematic scan of all mutations in a protein
chain (or group of chains), or at the protein–protein interface. Each binding epitope residue
for the studied complexes was systematically mutated using all possible substitutions and
the corresponding free energy changes were computed. The BeAtMuSiC approach is based
on statistical potentials describing the pairwise inter-residue distances, backbone torsion
angles, and solvent accessibilities, and considers the mutational effects on the binding
interactions and the overall thermal stability of the complex. The binding free energy of the
protein–protein complex can be expressed as the difference in the folding free energy of the
complex and folding free energies of the two protein binding partners:
∆Gbind = G com − G A − G B

(3)

The change in binding energy due to a mutation was calculated then as the following:
mut
wt
∆∆Gbind = ∆Gbind
− ∆Gbind

(4)

We leveraged rapid calculations using the BeAtMuSiC server to compute the ensembleaveraged binding free energy changes using equilibrium samples from MD trajectories.
The reported binding free energy changes are obtained by averaging the BeAtMuSiC results
over 100 equilibrium conformations for each of the studied systems.
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2.4. Network Analysis and Perturbation-Based Mutational Profiling of Allosteric Propensities
A graph-based representation of the protein structures [100,101] is used to represent
residues as network nodes and the inter-residue edges to describe non-covalent residue interactions. The network edges that define residue connectivity are based on non-covalent interactions between the residue side-chains. We constructed the residue interaction networks
using dynamic correlations [102] that yield robust network signatures of long-range couplings and communications. The Residue Interaction Network Generator (RING) program
was employed for the initial generation of residue interaction networks based on the single
structure [103] and the conformational ensemble [104], where edges have an associated
weight reflecting the frequency in which the interaction present in the conformational ensemble. The residue interaction network files in xml format were obtained for all structures
using the RING v3.0 webserver freely available at https://ring.biocomputingup.it/submit
(accessed on 15 May 2022). Network graph calculations were performed using the python
package NetworkX [105]. Using the constructed protein structure networks, we computed
the residue-based betweenness parameter. The short path betweenness centrality of residue
i is defined to be the sum of the fraction of the shortest paths between all pairs of residues
that pass through residue i:
N g (i )
jk
(5)
Cb (ni ) = ∑
g jk
j<k
where g jk denotes the number of shortest geodesics paths connecting j and k; and g jk (i )
is the number of shortest paths between residues j and k passing through the node ni .
The betweenness centrality metric is also computed by evaluating the average shortest
path length (ASPL) change by systematically removing individual nodes [106,107]. The
following Z-score is then calculated:
Zi =

Bk − h Bi
σ

(6)

Through mutation-based perturbations of the protein residues we computed the dynamic couplings of residues and changes in the average short path length (ASPL) averaged
over all modifications in a given position. The change in ASPL upon mutational changes
of each node is inspired and reminiscent of the calculation proposed to evaluate residue
centralities by systematically removing nodes from the network.
∆Li = h ∆Linode ( j)

2

i

(7)

where i is a given site; j is a mutation; and h· · · i denotes averaging over mutations. ∆Linode ( j)
describes the change in ASPL upon mutation j in a residue node i. ∆Li is the average change
in ASPL induced by all mutations of a given residue. The Z-score is then calculated for
each node as follows:
∆Li − h∆Li
Zi =
(8)
σ
where h∆Li is the change in ASPL under mutational scanning averaged over all protein
residues in the S-RBD and σ is the standard deviation. The ensemble-averaged Z–score
ASPL changes were computed from a network analysis of the conformational ensembles
using 1000 snapshots of the simulation trajectory for the native protein system.
3. Results and Discussion
3.1. Structural Analysis of the S-RBD Complexes with Antibodies
We began with the structural analysis of the S-RBD binding with single antibodies A2358.1 (Figure 1A–C) and B1-182.1 (Figure 1D–F). The cryo-EM structures of the S-RBD WA1
complexes showed that both antibodies adapt the mode of binding by directly blocking the
interaction of the RBD with ACE2 and could be classified as either class I (ACE2 blocking,
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antibodies.
(A)
The
cryo-EM
structure
of
the
S-RBD
WA1
complex
with
A23-58.1.
The
antibodies. (A) The cryo-EM structure of the S-RBD WA1 complex with A23-58.1. The S-RBD is
in S-RBD is
green, the binding epitope residues are colored in red, and the antibody is shown in ribbons. The
heavy chain of A23-58.1 is in magenta and the light chain in cyan. (B) The S-RBD is shown in green
with the binding epitope residues in red and the RBD sites of the Omicron mutations (G339, S371,
S373, S375, K417, N440, G446, S477, T478, E484, Q493, G496, Q498, N501, and Y505) are colored in
pink. (C) A detailed closeup of the interacting residues in the binding interface of the S-RBD complex
with A23-58.1. The S-RBD binding residues are shown in green sticks and annotated. The contact
sites of the heavy antibody chain are in magenta spheres and in cyan spheres for the light chain
residues. (D) The cryo-EM structure of the S-RBD WA1 complex with B1-182.1 antibody. The S-RBD
is in green, the binding epitope residues are colored in red, and the antibody is shown in ribbons.
The heavy chain of is in magenta and the light chain in cyan. (E) The S-RBD green surface with the
binding epitope residues in red and the RBD sites of Omicron mutations in pink. (F) A closeup of the
interacting residues in the binding interface of the S-RBD complex with B1-182.1. The S-RBD-binding
residues are shown in green sticks and annotated, and the contact sites on the antibody are shown in
magenta and cyan spheres for the heavy and light chains, respectively.
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plex with A23-58.1. The S-RBD binding residues are shown in green sticks and annotated. The contact sites of the heavy antibody chain are in magenta spheres and in cyan spheres for the light chain
residues. (D) The cryo-EM structure of the S-RBD WA1 complex with B1-182.1 antibody. The S-RBD
is in green, the binding epitope residues are colored in red, and the antibody is shown in ribbons.
The heavy chain of is in magenta and the light chain in cyan. (E) The S-RBD green surface with the
binding epitope residues in red and the RBD sites of Omicron mutations in pink. (F)
A 29
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the interacting residues in the binding interface of the S-RBD complex with B1-182.1. The S-RBDbinding residues are shown in green sticks and annotated, and the contact sites on the antibody are
shown in magenta and cyan spheres for the heavy and light chains, respectively.
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Figure 2. Structural
the SARS-CoV-2
RBD complex
the combination
of A19- of A1961.1/B1-182.1 antibodies. (A) The cryo-EM structure of the S-RBD WA1 complex with the A1961.1/B1-182.1 antibodies. (A) The cryo-EM structure of the S-RBD WA1 complex with the A1961.1/B1-182.1 pair. The S-RBD is in green, the binding epitope residues are colored in red. The heavy
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S-RBD complex with B1-182.1 and A19-61.1, respectively. The S-RBD binding residues are shown
in green sticks and annotated. The contact sites of the interacting antibodies are shown in spheres
colored according to the established color scheme for the heavy and light chain. (E) The structure of
the S-RBD WA1 complex with A19-61.1/B1-182.1 with the sites of the Omicron mutations. The S-RBD
is in orange ribbons, and the Omicron sites are in red spheres and annotated. B1-182.1 is shown in
surface colors (heavy chain in magenta, light chain in cyan) and A19-61.1 is also in surface colors
(heavy chain in blue, light chain in pink). (F) The S-RBD (green) with the binding epitope residues is
highlighted in red and sites of the Omicron mutations are in pink.

The peripheral interactions formed by the T478 and Q493 residues are also maintained
in the complex, which reflects a considerable structural similarity to the S-RBD WA1
complexes with a single B1-182.1 and A19-61.1/B1-182.1 combination. The binding interface
of A19-61.1 is determined by K444, G446, and Y449 residues that penetrate into a cavity
formed by the heavy chain residues H109, N112, I102, and V104 and the light chain
residues S31, W32, and D50 (Figure 2D). Noticeably, the functionally important Q493
residue interacts with both B1-182.1 and A19-61.1 antibodies, suggesting the potential
importance of this position in the stability of the complex and allostery. Indeed, Q493 forms
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interactions with G53, G55, and N56 of the B1-182.1 heavy chain, and with A105 and T107
of the A19-61.1 heavy chain (Figure 2C,D). Other important contacts with A19-61.1 are
mediated by N450, L452, and F490 (Figure 2D). Structural maps of the binding epitope
residues and sites of Omicron mutations in the complex (Figure 2E,F) showed that the
Omicron positions are generally either on the edges of the binding epitope or outside
of the epitope regions, with the exception of the G446 position that at the core of the
binding interface.
The cryo-EM structure of the S-RBD Omicron with the A19-46.1/B1-182.1 combination
revealed a similar binding mode for B1-182.1 as in the S-RBD/B1-182.1 complex, while
highlighting a more specific orientation and angle of approach for the A19-46.1 antibody
(Figure 3A,B). The binding epitope residues for B1-182.1 in the S-RBD Omicron complex
with A19-46.1/B1-182.1 (Figure 3A,B) are essentially identical to those in the S-RBD WA1
complex with A19-61.1/B1-182.1 (Figure 2A,B). It can be noticed that the binding epitope
for A19-46.1 has a substantial overlap with A19-61.1 but also featured a stretch of RBD
residues 345-354, as well as residues D420, Y421, I468, S469, I470, E471, and A484 in the
binding epitope that are specific for A19-46.1 (Figure 3A,B). The primary contacts formed
by S-RBD Omicron with B1-182.1 are similarly mediated by the hydrophobic sites F456,
F486, and Y489, particularly between F486 and heavy chain positions A33, P95, and D100
and light chain residues S31, Y32, Y91, and W96 (Figure 3C). The interaction contacts also
engage Y473, N477, and K478 residues in binding with B1-182.1 (Figure 3C). The dominant
contacts
with the A19-46.1 antibody are mediated by the Y449 and F490 residues interacting 12
Biomolecules 2022, 12,
964
with multiple sites in both the heavy and light antibody chains (Figure 3D).
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by the functionally important Omicron position A484 with the light chain residues Y33
and S26 of A19-26.2 (Figure 3D). Interestingly, a number of Omicron sites belong to or are
located on the edges of the extended binding epitope, including K440, S446, K417, N477,
K478, A484, R493, and S496 (Figure 3E,F). Overall, structural analysis of the S-RBD WA1
and Omicron complexes with a panel of antibodies revealed a complex pattern of binding
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Additional interaction contacts feature RBD residues Y351, N450, L452, and Q493. The
important new contacts formed by the S-RBD Omicron with A19-46.1 are established by the
functionally important Omicron position A484 with the light chain residues Y33 and S26 of
A19-26.2 (Figure 3D). Interestingly, a number of Omicron sites belong to or are located on
the edges of the extended binding epitope, including K440, S446, K417, N477, K478, A484,
R493, and S496 (Figure 3E,F). Overall, structural analysis of the S-RBD WA1 and Omicron
complexes with a panel of antibodies revealed a complex pattern of binding interactions
and binding interfaces that are often dominated by nonpolar interactions formed by a
group of hydrophobic residues—Y449, Y453, L455, A475, F456, F486, Y489, and F490—that
are important for RBD stability and binding with the host receptor, and where mutations
occur only at a very low frequency (<0.05%) [56].
The central question addressed in our study is how these ultra-potent antibodies
manage to mitigate mutational escape by the Omicron variant and elicit their neutralization
potential given the noticeable presence of the Omicron positions in the binding epitope. We
performed a comprehensive computational analysis and mutational profiling of the Omicron RBD–antibody complexes to characterize the dynamic, energetic, and allosteric factors
that can be associated with the antibody escape mechanism and explain the experimentally
observed mutational escape patterns.
3.2. MD Simulations and Distance Fluctuation Analysis of Conformational Ensembles of the
S-RBD Complexes with Antibodies Reveal Specific Dynamic Signatures and Stability Centers
All-atom MD simulations were performed for the S-RBD WA1 and S-RBD Omicron
complexes with the antibodies. Conformational dynamics profiles are described using the
root mean square fluctuations (RMSF) obtained from simulations (Figure 4). The conformational mobility distribution for the S-RBD complex with A23-58.1 and B1-182.1 were
similar, showing several deep local minima corresponding to residues 374–377, the RBD
core residue cluster (residues 396–403), residues 445–456 that contain β-sheet β5 (residues
451–454) (Figure 4). We observed that the mobile flexible RBM loops (residues 473–487)
become partly constrained in the complex, owing to the stabilizing contacts with B1-182.1
antibody that reduce local fluctuations in this region. Noticeably, residues 470–480 retain a
certain degree of flexibility in the complex despite forming a portion of the intermolecular
interface. At the same time, residues 481–495 experience only minor fluctuations. The RBM
residues 501–510 that are exposed to solvent showed more significant displacements. A
similar pattern of thermal fluctuations was observed in simulations of the S-RBD complex
with A19-61.1/B1-182.1 pair (Figure 4). The most stable RBD positions corresponded
to the RBD core residue clusters (residues 396–403 and 430–435). Interestingly, the RBD
residues 440–452 involved in the contacts with A19-61.1 showed minor fluctuations, while
the binding epitope region 470–485 retained a moderate mobility, and the RBD binding
interface sites 486–493 showed reduced fluctuations (Figure 4). The most interesting and
intriguing pattern of the RBD dynamics was observed in the S-RBD Omicron complex with
A19-46.1/B1-182.1 antibodies. The dynamic profile showed a greater mobility of the S-RBD
regions outside of the binding interface (residues 360–395). At the same time, the dynamic
profile featured a number of deep local minima in the specific regions, highlighting stabilization of residue clusters 395–403, 420–423, 448–452, and 490–493 (Figure 4). By mapping
positions of the Omicron mutations on the dynamics profiles, it could be seen that S371L,
S373P and S375F positions experience more appreciable fluctuations, while the reduced
mobility in K417N, N440 and G446S may be attributed to the stabilizing interactions with
A19-46.1/B1-182.1 antibodies. Despite the intermolecular contacts, the RBM tip positions
S477N, T478K remained moderately flexible, but the Omicron positions Q493R and G496S
are involved in strong interactions with the antibodies and correspond to well-defined local
minima of the dynamics profile signaling their considerable stabilization in the complex
(Figure 4). The important implication of these observations is that conformational plasticity
of the S-RBD Omicron can be retained in the complex with the antibodies, yielding a rather
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narrow range of highly stabilized sites induced by binding which could potentially limit
the repertoire of resistant mutations.

Figure 4. Conformational dynamics profiles obtained from simulations of the SARS-CoV-2 S-RBD
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an appreciable rise in the number of stable interactions formed by the charged residues
(Table 2). Of particular importance are the multiple stable contacts mediated by the S-RBD
Omicron residues K444, K458, K478, R346, and R493. Our analysis supports the notion
that the electrostatic interactions could play an important stabilizing role in the S-RBD
complexes with ultrapotent antibodies [109,110]. Recent quantitative assessment of the
antibody escape showed that the S-RBD Omicron variant can be resistant to most neutralizing antibodies, primarily due to either unfavorable or only partly optimized electrostatic
interactions [111,112]. Indeed, according to the experiments [51,52], the escaping mutations for the studied ultrapotent antibodies can emerge in the charged positions K444
and R493 of the S-RBD Omicron, causing a modest ~5–7-fold decrease in neutralization,
attributed to only partially optimized electrostatic contacts. Consistent with the related
studies [109–112], our analysis similarly indicated that potent antibodies against S-RBD
Omicron should be enriched with negatively charged residues in positions interacting with
the Omicron positively charged mutational sites. At the same time, a far more significant
increase was seen in the number of hydrophobic contacts in the S-RBD and S-RBD Omicron
complexes with the synergistic antibody pairs (Table 2). This analysis suggested that the
hydrophobic interactions with the conserved RBD sites combined with the favorable electrostatic contributions may be dominant factors driving the improved binding affinities for
the examined ultrapotent antibodies capable of neutralizing the Omicron spike variant. In
general, the ensemble-based analysis of the interfacial residue-residue contacts revealed the
chemical nature of the most relevant binding interactions, also highlighting the connection
between the major interaction patterns and potential antibody escape mechanisms.
Table 2. Ensemble-averaged statistics of interfacial residue–residue contacts in the SARS-CoV-2
S-RBD complexes examined in this study.
Interfacial
Contacts

RBD
A23-58.1

RBD
B1-182.1

RBD
A19-61.1/B1-182.1

RBD Omicron
A19-46.1/B1-182.1

Charged–charged

3

4

7

8

Charged–polar

7

8

10

13

Charged–apolar

2

5

17

11

Polar–polar

3

4

6

3

Polar–apolar

13

21

27

26

Apolar–apolar

22

24

39

35

∆G comput. (kcal/mol)

−8.5

−10.3

−12.9

−12.6

Kd (nM) experiment

7.3

2.55

2.33 (A19-61.1)

3.58 (A19-46.1)

Using conformational ensembles of the S-RBD complexes, we then computed the
fluctuations of the mean distance between each residue and all other protein residues. The
resulting distance fluctuation stability indexes measure the energetics of the residue deformations and can point to the regions of protein stability and flexibility (Figures 5 and 6).
The high values of the distance fluctuation indexes are typically associated with globally
stable residues as they display small fluctuations in their distances to all other residues in
the protein system, while small values of this parameter would correspond to the flexible
sites that experience large deviations in their inter-residue distances. We first analyzed
the distributions of the S-RBD WA1 complexes with A23-58.1 (Figure 5A,B) and B1-182.1
(Figure 5C,D). We observed several dominant and common peaks reflecting similarity to
the topological and dynamical features of these S-RBD complexes. The RBD profiles for
both complexes revealed a consistent pattern of local maxima that are aligned with the
antibody-interacting positions K417, Y421, Y453, L455, F456, Y473, F486, N487, and Y489
(Figure 5A,C). Strikingly, the most dominant stability hotspots in the S-RBD complexes
with A23-58.1 and B1-182.1 coreponded to the conserved hydrophobic positions L452, L455,
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L455, F456, Y473, F486, Y489, F490, and L492 hydrophobic sites correspond to the protein
stability hotspots, suggesting that the repertoire of antibody escape mutations in these
sites may be extremely limited as it would incur a significant stability fitness cost. These
findings are consistent with the recent studies showing that residues Y449, L452, L455,
E484, Y489, F490, L492, Q493, and S494 can be among the immune-escaping hotspots that
may destabilize binding with antibodies and erode neutralizing immune responses [116].
Furthermore, mutations of the common hydrophobic hotspots (Y449, Y473, L455, F456,
and Y489) can disrupt both the stability of the RBD and binding to ACE2 and ultra-potent
neutralizing antibodies [115]. Hence, mutations of these hotspots can compromise the
balance of multiple fitness trade-offs of the virus, specifically between immune escape,
RBD stability, and the affinity with the ACE receptor. Another important revelation of
the distance fluctuation analysis is that the Omicron sites displayed only moderate or
low stability indexes, which reflected conformational flexibility of these residues even
when they engage in the interactions with the antibodies (Figure 5A,B). It is also worth
pointing out that only a single Omicron position, Q493, displayed a moderate-high value
in the stability index, indicating that substitutions in this site may potentially produce
antibody-escaping mutants. Consistent with the predicted moderate stability effect, only
marginal B1-182.1 escape can be mediated by Q493R but with minor impact on binding
and no appreciable reduction of the neutralization activity [51].
The distance fluctuation stability profile for the S-RBD complex with the A19-61.1/B1182.1 antibody combination showed an overall similar profile, reinforcing the notion that
a subset of stability hotspots on the RBD may be preserved across the S-RBD complexes
(Figure 6A). The major stability profile peaks corresponded to the hydrophobic sites V350,
V401, I402, L455, F456, Y473, A475, F486, and Y489 (Figure 6A). In addition, functional
positions Q493 and S494 corresponded to the largest peak in the distance fluctuation profile,
reflecting antibody-induced stabilization of these sites that are more flexible in the unbound
form. Moreover, the Q493 residue interacts with both B1-182.1 and A19-61.1 antibodies, and
the increased stabilization of this site may be also associated with its potential mediating
role in the long-range intermolecular interactions in the complex. Interestingly, several
A19-61.1-interacting positions, such as G446 and L452, featured among the moderate
local peaks of the distribution (Figure 6A). In this context, it is worth noting that A1961.1 escape mutations include G446V/S and S494R that occur at the exceptionally low
frequency [51,52], which is consistent with the role of these sites as the protein stability
hotspots in the complexes. The distance fluctuation profile for the B1-182.1 antibody
showed strong peaks for residues 50–52 of the heavy chain (Figure 6B) that interacts with
the RBD stability centers F486, Y489, and F490. The distribution for the A19-61.1 antibody
displayed the largest peak for residues 107–112 of the heavy chain (Figure 6C) that interface
with the K444, G446, Y449, and L452 positions on the RBD. The observed distribution
patterns for the interacting antibodies A19-61.1 and B1-182.1 reflected stabilization of the
key intermolecular interfaces and have a mediating role in the RBD stability centers G446,
Y449, L452, F486, Y489, and F490. These positions are often targeted by class I and II
antibodies. Indeed, the most frequently targeted RBD residues by class I antibodies include
L455, F456, F486, N487, and Y489, while for class II antibodies the most targeted sites are
Y449, G485, and F486 [117].
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M94 that interface with the A484 and F486 RBD sites (Figure 6E), while the A19-46.1
antibody showed strong peaks for residues L24, S25, and S26 of the light chain of the
antibody that pack directly against A484 on the RBD (Figure 6F). In addition, some less
significant stability peaks were seen for the heavy chain residues L105, L106, P107, of
A19-46.1 (Figure 6F) packed against the RBD hotspots N450, Y451, and L452. Hence,
in the S-RBD Omicron complex with A19-46.1/B1-182.1, one hotspot cluster is centered
around the A484 position interfacing with both antibodies, while several additional stability
centers are mediated by the N450, L452, and F490 positions that are engaged in binding
with the A19-46.1 antibody. Another important finding of our analysis is that the Omicron
mutational sites in these complexes typically featured small distance fluctuation indexes
indicative of the conformational adaptability of these residues. Structural mapping of the
stability centers and Omicron mutation sites (Figure 6G,H) highlighted only small overlap
between these groups. In particular, for the S-RBD Omicron complex with A19-46.1/B1182.1, the structural projection of the stability centers mimicked a “pathway” that connects
the RBD core with the RBM residues serving as “bridges” between the synergistically
acting antibodies. It may be argued that this structural disposition of the stability centers is
associated with their role in mediating the long-range communications in the complex. In
some contrast, Omicron mutations are broadly distributed on the RBD binding interface
and create a dynamic “shield” surrounding the protein stability regions.
Combined, the results of the conformational dynamics and distance fluctuation analysis showed that the protein stability centers in the S-RBD complexes often corresponded
to the antibody-specific, immune-escaping hotspots. Importantly, the common stability
hotspots—Y449, Y473, L455, F456, F486, and Y489—in these complexes are constrained
by the requirements for the RBD folding and binding with the ACE2 host receptor, and
therefore may be limited in evolving antibody-escaping variants. Hence, protein stability signatures mediated by the antibody binding can affect the pattern of mutational
escape and be one of the important contributing factors that determines mechanisms of
immune evasion.
3.3. Ensemble-Based Mutational Scanning and Energetic Cartography Identifies Binding Affinity
Hotspots in the SARS-CoV-2 RBD Complexes with Ultrapotent Antibodies
By employing the conformational ensembles of the S-RBD WA1 and S-RBD complexes
with antibodies, we performed comprehensive mutational scanning of the interfacial RBD
residues and computed binding free energy changes. In silico mutational scanning was
done using the BeAtMuSiC approach [97–99]. This approach allows for accurate predictions
of the effect of mutations on the binding affinity and the protein stability of the complex. To
provide a comparison between the computational and experimental data, we constructed
mutational heatmaps for the RBD binding interface residues (Figure 7). Intriguingly, despite
structural similarities and common binding epitopes, binding heatmaps for the S-RBD WA1
complex with A23-58.1 (Figure 7A) and S-RBD Omicron complex with B1-182.1 (Figure 7B)
displayed appreciable differences and featured several unique mutational signatures. In
the S-RBD WA1 complex with A23-58.1, a fairly elevated level of mutational tolerance to
the binding interactions was observed for many epitope residues, including K417, L455,
Y473, A475, S477, T478, G485, and Q493 residues (Figure 7A). At the same time, the mutational heatmap clearly identified three major binding hotspots in the F456, F486, and Y489
positions, where particularly large destabilization changes were induced by mutations of
the F486 residue (Figure 7A). These results agree with the experimental data, showing that
the binding and neutralization capacity of A23-58.1 can be markedly reduced by mutations
in F486 and Y489 (particularly F486R/S, Y489R) and partly impaired by some mutations in
F456 (F456R/Q/S) [51]. Consistent with the experiments, our energetic analysis showed
that the F486Q, F486R, and F486S mutations yielded the most significant destabilization: ∆∆G = 3.74 kcal/mol, ∆∆G = 3.75 kcal/mol, and ∆∆G = 4.04 kcal/mol, respectively
(Figure 7A). According to the mutational scanning analysis, mutations in the Omicron
sites S477, T478, and Q493 caused only moderate destabilization changes, with S477N,
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T478K, and Q493R substitutions yielding ∆∆G = 0.14 kcal/mol, ∆∆G = 0.73 kcal/mol, and
∆∆G =0.33 kcal/mol, respectively, for the A23-58.1 antibody (Figure 7A). This is consis58.1
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A more complex picture emerged from the mutational heatmaps of the S-RBD complex with B1-182.1/A19-61.1 (Figure 7C) and the S-RBD Omicron complex with B1182.1/A19-46.1 (Figure 7D). In both complexes, the key binding hotspots corresponded to
the Y449, F456, F486, Y489, and F490 positions. Of particular significance is the fact that
the conserved hydrophobic residues Y449, Y453, L455, F486, Y489, and F490 consistently
emerged not only as the key stability centers but also as the dominant binding hotspots in
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agreement with the pioneering structure–function experiments [51,52] that emphasized
the role of the G446S mutation causing a complete loss in activity for A19-61.1 against the
Omicron variant. The energetic heatmap analysis of the S-RBD Omicron complex with
A19-46.1/1-182.1 (Figure 7D) detailed the mutational sensitivity of residues Y449, N450,
20 of
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L452, and F490 that are targeted by escape mutations Y449S, N450S, N450Y, and
L452R
[51,52].
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between various fitness tradeoffs, perturbing the intrinsic RBD stability and compromising binding to ACE2 [116]. These factors may narrow the “ evolutionary path” for the
virus to adopt escape mutations in these key binding hotspots, thereby allowing for the
cross-reactive antibodies to retain their neutralization efficiency. We also observed a strong
binding sensitivity of A19-61.1 to mutations in the G446 and Q493 positions, particularly
Omicron mutations G446S and Q493R (Figure 7C). These results are in excellent agreement
with the pioneering structure–function experiments [51,52] that emphasized the role of the
G446S mutation causing a complete loss in activity for A19-61.1 against the Omicron variant.
The energetic heatmap analysis of the S-RBD Omicron complex with A19-46.1/1-182.1
(Figure 7D) detailed the mutational sensitivity of residues Y449, N450, L452, and F490 that
are targeted by escape mutations Y449S, N450S, N450Y, and L452R [51,52].
3.4. Allosteric Mutational Profiling of the Interaction Networks in the S-RBD Complexes Discern
Sites and Mechanisms of Mutational Escape
We performed dynamic network analysis of the conformational ensembles and employed a recently introduced perturbation-based network approach for mutational scanning
of allosteric residue potentials [72] to characterize the allosteric interaction networks and
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identify allosteric hotspots in the S-RBD complexes. In the proposed model, allosteric
hotspots are identified as residues in which mutations incur significant edgetic perturbations of the global residue interaction network that disrupt the network connectivity and
cause a significant impairment in the global network communications. Using a graphbased network model of the residue interactions in which the network edges between
nodes are weighted using dynamic residue–residue correlations obtained from the MD
simulations, we computed the ensemble-averaged distributions of several residue-based
topological network metrics (Figures 9 and 10). The short path residue centrality (SPC)
is used to analyze the modularity and community organization of the dynamic residue
interaction networks. The SPC distributions reflect the extent of the residue connectivity
in the interaction networks and allow for characterization of the mediating clusters in
the complexes. The Z-score betweenness centrality is based on computing the average
shortest path length (ASPL) as outlined in detail in the Methods section. By systematically
introducing mutational changes in the S-RBD positions and using the equilibrium ensemble
of the original system, we reevaluate the dynamic inter-residue couplings and compute
mutation-induced changes in the ASPL parameter. These changes are then averaged over
all substitutions in a given residue. In this manner, we characterized the average mutational
sensitivity of each residue node on the changes in the network modularity and allosteric
communications. By identifying residues where mutations on average induce a significant
increase in the ASPL metric and therefore have a dramatic effect on the allosteric interaction
23 of 31
network, we locate allosteric control points and regulatory hotspots that control long-range
communications in the S-RBD complexes.
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In the S-RBD complex with A19-61.1/B1-182.1, the shape of the SPC centrality profile
is similar, but the most allosterically sensitive to mutation positions corresponded to the
Y451, Y453, S494, and Y495 residues (Figure 10A). These peaks were further accentuated
in the Z-score ASPL profile (Figure 10B), indicating that mutations of these residues may
perturb network connectivity and alter allosteric interactions in the S-RBD complex.
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For the S-RBD Omicron complex with A19-46.1/B1-182.1, we found that N450, L452,
The SPC distribution for the S-RBD complexes with A23-58.1 (Figure 9A) and B1-182.1
and S494 are the dominant peaks of the SPC and ASPL distributions (Figure 10C,D) and
antibodies (Figure 9B) revealed dense clusters of high centralities in the regions that are
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to potential allosteric hotspots of the interaction network in which mutations
often aligned with the stability centers. The emergence of local clusters of mediating
can
markedly
alter
the efficiency
of the long-range
interactions.
These
positions
also
residues implies
a high
level of connectivity
in the residue
interaction
network,
whichare
may
binding
epitope
While mutational
substitutions
these
allow for
diverseresidues.
communication
routes in thescanning
complex.showed
The highthat
centrality
peaks inof
both
sites
induce
appreciable
binding
affinity
losses,
the
binding
free
energy
changes
for
the S-RBD complex with A23-58.1 corresponded to the hydrophobic sites V350, V401, I402,the
experimentally
observed
escape
mutations
L452R
[51,52]isare
W436, Y453, L455,
S494, and
Y495 (Figure
9A). N450S,
A similarN450Y,
but lessand
dense
distribution
seennot
markedly
different
from
mutation-induced
destabilization
epitope sites.
Strucin the S-RBD
complex
with
B1-182.1 (Figure 9B).
The key peaksin
in other
this distribution
are I402,
Y423,mapping
F456, L461,
Y473 residues.
Interestingly,
the the
mediating
clusters
of the
long-range
tural
of and
the allosteric
centers
highlighted
proximity
of the
stable
allosteric
interactions
in these complexes
anchored the
by aconnectivity
group of residues
only partly
overlap
centers
and Omicron
sites, alsoare
illustrating
of thethat
allosteric
hotspots
linkwith
the
stability
and
binding
hotspots.
We
noticed
that
the
Omicron
positions
K417
and
ing the RBD core with the intermolecular interfaces (Figure 10E,F).
Q493
displayed
SPC values,
these sites antibodies
also can be target
involved
in
Overall,
thismoderate
analysis showed
thatindicating
the potentthat
neutralizing
a privimediating
interactions.
Perturbation-based
scanning
of allosteric
leged
groupallosteric
of the RBD
residues that
form the bindingmutational
hotspots but
also serve
as protein
residue
propensities
provided
information
about
potential
allosteric
hotspots
by
mapping
stability and allosteric control centers. As a result, the repertoire of antibody escape
mua space of network-altering, allosteric, ‘edgetic’ variant sites (Figure 9C,D). In this model,
tations can be significantly curtailed, as modifications in these positions may compromise
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bility requirements, and long-range allosteric effects. These results support the recent biophysical experiments showing that the differences in the mechanical stability of the SRBD interactions with ACE2 and antibodies may determine fitness advantages and describe more accurately the thermodynamics and kinetics of the binding mechanisms and

Biomolecules 2022, 12, 964

23 of 29

Indeed, in the S-RBD complex with A23-58.1, the key allosteric hotspots revealed by
the Z-score ASPL profile were aligned with the I402, W436, Y453, L455, S494, and Y495
positions (Figure 9C), while in the complex with the B1-182.1 antibody, the major peaks
singled out Y423, L455, F456, L461, and Y473 residues (Figure 9D). In network terms,
mutations in these positions could affect multiple intra- and inter-molecular interactions
altering the network connectivity, which could adversely affect the long-range allosteric
interactions. This analysis revealed several antibody-specific allosteric centers, such as
Y453, S494, and Y495, in the complex with A23-58.1, while L461 and Y473 in the complex
with the B1-182.1 antibody. Notably, the sites of the Omicron mutations in these S-RBD
complexes featured small Z-score ASPL values in both complexes, indicating that allosteric
communications between the S-RBD and antibodies may be tolerant to modifications in the
Omicron positions (Figure 9C,D). Structural projection of the allosteric centers showed that
the RBD positions mediating the network connectivity could form a “pathway” connecting
the RBD core with the central part of the binding interface (Figure 9E,F). The Omicron sites
occupy more flexible regions and are dynamically coupled with the stable allosteric centers.
In the S-RBD complex with A19-61.1/B1-182.1, the shape of the SPC centrality profile
is similar, but the most allosterically sensitive to mutation positions corresponded to the
Y451, Y453, S494, and Y495 residues (Figure 10A). These peaks were further accentuated
in the Z-score ASPL profile (Figure 10B), indicating that mutations of these residues may
perturb network connectivity and alter allosteric interactions in the S-RBD complex.
The results revealed that S494 residue is not only a protein stability center but also
an important allosteric mediating hotspot of long-range communications in the complex
with A19-46.1/B1-182.1. The experimental data showed that mutations in S494 (S494R
and S494P) can mediate a strong escape from A19-61.1 antibody binding [51]. According
to our analysis, this may result from the combined effect of multiple factors, including
the protein stability reduction, binding affinity loss, and also weakening of the allosteric
interactions in the complex. In particular, mutations of S494 can reduce binding by the
antibodies while having a minimal effect on the RBD–ACE2 binding [118]. In support
of the predicted allosteric role of the S494 position, recent experimental studies showed
that the neutralization potential of the potent antibodies may be significantly hampered
with the addition of synergetic mutations K417N/N501Y to E484K and E484K/N501Y to
S494P [118], suggesting a long-range cooperativity between sites of circulating mutations.
For the S-RBD Omicron complex with A19-46.1/B1-182.1, we found that N450, L452,
and S494 are the dominant peaks of the SPC and ASPL distributions (Figure 10C,D) and correspond to potential allosteric hotspots of the interaction network in which mutations can
markedly alter the efficiency of the long-range interactions. These positions are also binding
epitope residues. While mutational scanning showed that substitutions of these sites induce
appreciable binding affinity losses, the binding free energy changes for the experimentally
observed escape mutations N450S, N450Y, and L452R [51,52] are not markedly different
from mutation-induced destabilization in other epitope sites. Structural mapping of the
allosteric centers highlighted the proximity of the stable allosteric centers and Omicron
sites, also illustrating the connectivity of the allosteric hotspots linking the RBD core with
the intermolecular interfaces (Figure 10E,F).
Overall, this analysis showed that the potent neutralizing antibodies target a privileged group of the RBD residues that form the binding hotspots but also serve as protein
stability and allosteric control centers. As a result, the repertoire of antibody escape mutations can be significantly curtailed, as modifications in these positions may compromise
the RBD folding stability, affect ACE2 binding, and also alter the long-range interactions
and allosteric communication in the S-RBD complexes. Our results suggest that the experimentally observed escape mutants for the studied antibodies may be determined by
the cumulative contribution and fitness tradeoffs of the local binding interactions, protein stability requirements, and long-range allosteric effects. These results support the
recent biophysical experiments showing that the differences in the mechanical stability
of the S-RBD interactions with ACE2 and antibodies may determine fitness advantages
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and describe more accurately the thermodynamics and kinetics of the binding mechanisms
and immune evasion patterns [41–43]. Noteworthy, caution needs to be exercised when
inferring evidence of a direct causal association between the antibody escape mechanisms
and the confluence of the examined molecular factors. The results presented in this study
suggest that the antibody escape patterns may be linked with a complex balance of binding,
protein stability, and allostery factors, but certainly only indicate the observed association
that requires further investigation. The integration with the biophysical and cell-based
experiments may help to unveil the important signals of mutational escape at the molecular
and cellular level, allowing to quantify the determinants of the immune evasion.
4. Conclusions
The integrated computational analysis of the S-RBD Omicron complexes with a set
of ultra-potent antibodies revealed several important structural and energetic factors contributing to the mutational escape mechanism. Consistent with the experimental evidence,
mutational profiling of binding, protein stability, and allosteric interactions in the S-RBD
Omicron complexes revealed that the binding interactions and long-range communications
in the complexes are generally tolerant to the Omicron mutations. We found that the
neutralizing antibodies against the Omicron variant target the conserved protein stability
centers Y449, Y453, L455, F486, Y489, and F490, which emerged as the dominant binding
hotspots in the studied complexes. As a result, mutations in these residues that can severely
impair binding with the antibodies would also incur an unacceptable functional cost of disrupting the intrinsic RBD stability and compromising binding to ACE2. Perturbation-based
mutational scanning of allosteric residue propensities provided information about potential
allosteric hotspots by mapping a space of network-altering, allosteric, ‘edgetic’ variant sites.
By identifying residues where mutations on average induce a significant increase in the
ASPL metric, and therefore have a dramatic effect on the allosteric interaction network,
we located allosteric regulatory hotspots that control long-range communications in the
S-RBD complexes. We found that some allosteric centers mediating long-range interactions
correspond to the important sites of mutational escape—N450, L452, and S494—while
only moderately affecting the RBD–antibody binding. Together, the predicted energetic
tolerance of the antibody binding to Omicron mutations and the convergence between the
binding affinity hotspots, the protein stability centers, and allosteric control points support
a strong association between these effects and the observed antibody escape pattens. We
suggest that by specifically targeting these universal hotspots, the ultra-potent antibodies
could resist the Omicron mutations and limit the “evolutionary path” for the virus to adopt
viable escape mutants. In this scenario, the emergence of antibody escape mutations in
the binding hotspots may become restricted due to the RBD folding stability constraints,
the functional requirements for ACE2 binding, and the regulatory control of the structural
RBD transformations. The insights from this investigation suggest therapeutic venues for
targeted exploitation of the binding hotspots and allosteric centers that may potentially aid
in evading drug resistance.
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